0

Xstrahl is going to DEGRO 25; Join us at Booth B13

Xstrahl is delighted to invite you to join us at the 25th annual conference of the German Society of Radiation Oncology (DEGRO 25) taking place from the 13th to the 16th of June 2019 in the city [...]

0

Xstrahl In Action: Blockade of fibroblast activation protein and radiation treatment of pancreatic adenocarcinoma

Pancreatic ductal adenocarcinoma (PDAC) is characterized by a fibrotic stroma with a poor lymphocyte infiltrate, in part driven by cancer-associated fibroblasts (CAFs). CAFs, which express [...]

0

ICRR 2019

25 – 29 August 2019 (Manchester, UK)

0

16th International Tumor Microenvironment Workshop

13 – 15 June 2019 (Florida, US)

0

Xstrahl In Action: ATR kinase inhibitor enables T cell-dependent antitumor activity

DNA-damaging chemotherapy and radiation therapy are integrated into the treatment paradigm of the majority of cancer patients. Recently, immunotherapy that targets the immunosuppressive [...]

0

Xstrahl In Action: ATM inhibitors radiosensitize and improves survival of preclinical brain tumor models

Poor survival rates of patients with tumors arising from or disseminating into the brain are attributed to an inability to excise all tumor tissue (if operable), a lack of blood-brain barrier [...]

0

Xstrahl attended ESTRO 38 in Milan

Xstrahl has just returned from Milan, Italy, where it joined other leading system and software manufacturers to showcase the latest advances in radiation oncology at the annual European Society [...]